C3 Glomerulopathy: A Current Perspective in an Evolving Landscape
Background: C3 Glomerulopathy (C3G) is a heterogenous disease characterized by dysregulation of the complement alternative pathway (AP). Within 10 years of a diagnosis, roughly 50% of patients with C3G will progress to end stage kidney disease (ESKD). Historically, treatment options have been lim...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Karger Publishers
2024-10-01
|
| Series: | Glomerular Diseases |
| Online Access: | https://beta.karger.com/Article/FullText/542354 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|